Anthrax immunoglobulin

Active ingredient description

Anthrax immuneglobulin is a human immune globulin that is used in combination with antibiotics to treat anthrax. Anthrax immunoglobulin binds to protective antigen (PA) to prevent PA mediated cellular entry of anthrax edema factor and lethal factor.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BB Specific immunoglobulins
Discover more medicines within J06BB19

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Structured Product Labeling (SPL/PLR)
US

Medicines

Anthrax immunoglobulin is the active ingredient of these drugs:

Drug
Countries

United States

External identifiers

DrugBank Drug: DB09057
RxNorm Ingredient: 1722336
UNII Identifier: VKZ83S945Z
ANTHRAX IMMUNE GLOBULIN HUMAN